doi: 10.3389/fimmu.2024.1464329 Received 13 July 2024 Accepted 17 September 2024 Published 07 October 2024 Volume 15 - 2024 Edited by Philip Calder, University of Southampton, United Kingdom Reviewed by Md Tajmul, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), United States Isaacson Bababode Adelani, Johns Hopkins Medicine, United States Updates Copyright 2024 Munteanu, Mrza and Papuc
FDA scientists flag concerns with peptides, the trendy molecules RFK Jr
Clinical studies suggest inositol supplements may be beneficial for those with metabolic syndrome ( Metabolic syndrome is a group of conditions that raise your risk of chronic disease, including heart disease and type 2 diabetes
GHRP-6 co-elevates cortisol, ACTH, and prolactin stress and pituitary hormones that confound research readouts
Australias Chief Medical Officer, Professor Michael Kidd, has issued an urgent plea for patients to stay away from illegal peptides amid mounting reports of serious adverse reactions
PubMed: (peer-reviewed) Borkow G, et al